International Journal of Personality Psychology (May 2024)
The Personality Inventory for DSM-5-Brief Form (PID-5-BF): Psychometric indicators in a Brazilian community sample
Abstract
Objective: To investigate psychometric properties (internal structure, convergent/discriminant validity, internal consistency, and test-retest) of the Personality Inventory for DSM-5-Brief Form (PID-5-BF) in a Brazilian community sample. Method: This is a study with a psychometric design. A sample of 527 adults from the general population (69.9% women; 33.5 ± 14.0 years; 74.0% ≥ 12 years education) responded to the instrument online after the study was disseminated on social networks and to the researchers’ contacts. The NEO-PI-R and sociodemographic questionnaire were applied besides the PID-5-BF, and a retest was applied 15-30 days after the initial assessment for reliability assessment. Data were analyzed using statistical techniques (IBM SPSS19 and Factor20); the significance level was set at p ≤ 0.05 for all the analyses. Results: Internal consistency was verified using Cronbach’s alpha and was adequate (domains α ≥ 0.69; total α = 0.87), in addition to test-retest reliability (domains ICC ≥ 0.82; total ICC = 0.95). Divergences were found between the PID-5-BF different domains despite them being significantly correlated with each other. Convergent validity with the NEO-PI-R was adequate, with moderate/strong correlations between the domains theoretically associated (r > 0.38). The internal structure (Exploratory Factor Analysis) indicated that the original five-factor model (CFI = 0.991; TLI = 0.986; RMSEA = 0.033) and one-factor model were adequate (CFI = 0.908; TLI = 0.899; RMSEA = 0.089. Conclusions: The findings support using the PID-5-BF Brazilian version, which presented adequate psychometric properties comparable to the original version. This instrument can be helpful in the clinical and research fields to screen general and specific traits of personality pathology. Future studies are suggested to expand the psychometric findings among clinical samples, confirming the instrument’s scope of reach.
Keywords
